Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the costs and health effects of a range of interventions for preventing the spread of HIV and for treating people with HIV/AIDS in the context of the millennium development goal for combating HIV/AIDS. DESIGN: Cost effectiveness analysis based on an epidemiological model. SETTING: Analyses undertaken for two regions classified using the WHO epidemiological grouping-Afr-E, countries in sub-Saharan Africa with very high adult and high child mortality, and Sear-D, countries in South East Asia with high adult and high child mortality. DATA SOURCES: Biological and behavioural parameters from clinical and observational studies and population based surveys. Intervention effects and resource inputs based on published reports, expert opinion, and the WHO-CHOICE database. MAIN OUTCOME MEASURES: Costs per disability adjusted life year (DALY) averted in 2000 international dollars (Int dollars). RESULTS: In both regions interventions focused on mass media, education and treatment of sexually transmitted infections for female sex workers, and treatment of sexually transmitted infections in the general population cost < Int150 dollars per DALY averted. Voluntary counselling and testing costs < Int350 dollars per DALY averted in both regions, while prevention of mother to child transmission costs < Int50 dollars per DALY averted in Afr-E but around Int850 dollars per DALY in Sear-D. School based education strategies and various antiretroviral treatment strategies cost between Int500 dollars and Int5000 dollars per DALY averted. CONCLUSIONS: Reducing HIV transmission could be done most efficiently through mass media campaigns, interventions for sex workers and treatment of sexually transmitted infections where resources are most scarce. However, prevention of mother to child transmission, voluntary counselling and testing, and school based education would yield further health gains at higher budget levels and would be regarded as cost effective or highly cost effective based on standard international benchmarks. Antiretroviral therapy is at least as cost effective in improving population health as some of these interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The World Health Report 2002 - Reducing Risks, Promoting Healthy Life
Not Available, N. A. (2003) · Education for Health: Change in Learning & Practice · doi:10.1080/1357628031000116808 · Cited by 6,046
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Where and why are 10 million children dying every year?
Black, R. E., Morris, S. S., & Bryce, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13779-8 · Cited by 2,460
World development report 1993 : investing in health
Berkley, S., Bobadilla, J., Hecht, R., Hill, K., Jamison, D. T. T., Murray, C. J. L., Musgrove, P., Saxenian, H., & Tan, J. (1993) · Cited by 2,410
The economic and social burden of malaria
Sachs, J., & Malaney, P. (2002) · Nature · doi:10.1038/415680a · Cited by 2,248
WHO estimates of the causes of death in children
Bryce, J., Boschi-Pinto, C., Shibuya, K., & Black, R. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71877-8 · Cited by 2,096
How many child deaths can we prevent this year?
(2003) · Child: Care, Health and Development · doi:10.1046/j.1365-2214.2003.00376_6.x · Cited by 1,580
Grosskurth, H., Todd, J., Mwijarubi, E., Mayaud, P., Nicoll, A., ka-Gina, G., Newell, J., Grosskurth, H., Todd, J., Mayaud, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91380-7 · Cited by 1,406
Disease Control Priorities in Developing Countries
Mosley, W. H. (1993) · World Bank, Washington, DC eBooks · doi:10.1596/0-1952-0990-7 · Cited by 1,400
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial
Wawer, M. J., Sewankambo, N. K., Serwadda, D., Quinn, T. C., Kiwanuka, N., Li, C., Lutalo, T., Nalugoda, F., Gaydos, C. A., Moulton, L. H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06439-3 · Cited by 787
The Clinical Significance of Measles: A Review
Perry, R. T., & Halsey, N. A. (2004) · The Journal of Infectious Diseases · doi:10.1086/377712 · Cited by 628
Beston, G. H. (1992) · Cited by 589
Development of WHO guidelines on generalized cost-effectiveness analysis
Murray, C. J. L., Evans, D. B., Acharya, A., & Baltussen, R. M. P. M. (2000) · Health Economics · doi:10.1002/(sici)1099-1050(200004)9:3<235::aid-hec502>3.0.co;2-o · Cited by 577
Self-citationWhite, N., Nosten, F., Looareesuwan, S., Watkins, W., Marsh, K., Snow, R., Kokwaro, G., Ouma, J., Hien, T., Molyneux, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07367-x · Cited by 543
Generalized cost-effectiveness analysis for national-level priority-setting in the health sector
Hutubessy, R., Chisholm, D., Edejer, T. T.-T., & WHO-CHOICE (2003) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-1-8 · Cited by 535
Bhutta, Z. A., Bird, S. M., Black, R. E., Brown, K. H., Gardner, J. M., Hidayat, A., Khatun, F., Martorell, R., Ninh, N. X., Penny, M. E., et al. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.6.1516 · Cited by 515
Murray, C. J. L., & López, A. D. (1996) · Cited by 474
Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence
Creese, A., Floyd, K., Alban, A., & Guinness, L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08595-1 · Cited by 394
Programme costs in the economic evaluation of health interventions
Johns, B., Baltussen, R., & Hutubessy, R. (2003) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-1-1 · Cited by 329
Self-citationKamali, A., Quigley, M., Nakiyingi, J., Kinsman, J., Kengeya-Kayondo, J., Gopal, R., Ojwiya, A., Hughes, P., Carpenter, L., & Whitworth, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12598-6 · Cited by 318
Grosskurth, H., Gray, R., Hayes, R., Mabey, D., & Wawer, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02336-9 · Cited by 313
Cost-effectiveness of malaria control in sub-Saharan Africa
Goodman, C., Coleman, P., & Mills, A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02141-8 · Cited by 277
Delaying antimalarial drug resistance with combination chemotherapy.
White, N. J. (1999) · Parassitologia · Cited by 260
HIV prevention before HAART in sub-Saharan Africa
Marseille, E., Hofmann, P. B., & Kahn, J. G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08705-6 · Cited by 239
The impact of HIV and AIDS on Africa's economic development
Dixon, S. (2002) · BMJ · doi:10.1136/bmj.324.7331.232 · Cited by 226
The Role of Early HIV Infection in the Spread of HIV Through Populations
Koopman, J. S., Jacquez, J. A., Welch, G. W., Simon, C. P., Foxman, B., Pollock, S. M., Barth-Jones, D., Adams#, A. L., & Lange, K. (1997) · Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology · doi:10.1097/00042560-199703010-00009 · Cited by 223
Econometric estimation of country-specific hospital costs
Adam, T., Evans, D. B., & Murray, C. J. (2003) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-1-3 · Cited by 202
Schwartländer, B., Stover, J., Walker, N., Bollinger, L., Gutierrez, J. P., McGreevey, W., Opuni, M., Forsythe, S., Kumaranayake, L., Watts, C., et al. (2001) · Science · doi:10.1126/science.1062876 · Cited by 184
Caulfield, L. E., Huffman, S. L., & Piwoz, E. G. (1999) · Food and Nutrition Bulletin · doi:10.1177/156482659902000203 · Cited by 180
Can we reverse the HIV/AIDS pandemic with an expanded response?
Stover, J., Walker, N., Garnett, G. P., Salomon, J. A., Stanecki, K. A., Ghys, P. D., Grassly, N. C., Anderson, R. M., & Schwartländer, B. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09339-x · Cited by 170
Self-citationComparison of house spraying and insecticide-treated nets for malaria control.
(2000) · Europe PMC (PubMed Central) · Cited by 170
Integrating HIV Prevention and Treatment: From Slogans to Impact
Salomon, J. A., Hogan, D. R., Stover, J., Stanecki, K. A., Walker, N., Ghys, P. D., & Schwartländer, B. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020016 · Cited by 169
Self-citationMeta-analysis of intervention trials on case-management of pneumonia in community settings
Sazawal, S., & Black, R. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)91720-s · Cited by 168
Evans, D. B., Edejer, T. T.-T., Adam, T., & Lim, S. S. (2005) · BMJ · doi:10.1136/bmj.331.7525.1137 · Cited by 142
Pegurri, E., Fox-Rushby, J. A., & Damian, W. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.02.029 · Cited by 120
Staedke, S. G., Mpimbaza, A., Kamya, M. R., Nzarubara, B., Dorsey, G., & Rosenthal, P. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17478-3 · Cited by 113
Goodman, C. A., Mnzava, A. E. P., Dlamini, S. S., Sharp, B. L., Mthembu, D. J., & Gumede, J. K. (2001) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2001.00700.x · Cited by 103
Walker, D. G. (2003) · Health Policy and Planning · doi:10.1093/heapol/18.1.4 · Cited by 94
de Savigny, D., Kasale, H., Mbuya, C., & Reid, G. J. (2008) · Cited by 92
The economics of malaria control interventions
Hanson, K., Goodman, C. A., Lines, J., Meek, S., Bradley, D. J., & MILLS, A. J. (2004) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · Cited by 86
PopMod: a longitudinal population model with two interacting disease states
Lauer, J. A., Röhrich, K., Wirth, H., Charette, C., Gribble, S., & Murray, C. J. (2003) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-1-6 · Cited by 85
Self-citationCOLEMAN, P. G., Morel, C. M., Shillcutt, S. D., Goodman, C. A., & MILLS, A. J. (2004) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.196 · Cited by 78
Tackling HIV in resource poor countries
Mukherjee, J. S., Farmer, P. E., Niyizonkiza, D., McCorkle, L., Vanderwarker, C., Teixeira, P., & Kim, J. (2003) · BMJ · doi:10.1136/bmj.327.7423.1104 · Cited by 73
Guyatt, H. L. (2002) · Health Policy and Planning · doi:10.1093/heapol/17.2.144 · Cited by 69
Accounting for the cost of scaling‐up health interventions
Johns, B., & Baltussen, R. (2004) · Health Economics · doi:10.1002/hec.880 · Cited by 67
Self-citationKorenromp, E. L., Bakker, R., de Vlas, S. J., Gray, R. H., Wawer, M. J., Serwadda, D., Sewankambo, N. K., & Habbema, J. (2002) · AIDS · doi:10.1097/00002030-200211080-00014 · Cited by 64
Orroth, K. K., Korenromp, E. L., White, R. G., Changalucha, J., de Vlas, S. J., Gray, R. H., Hughes, P., Kamali, A., Ojwiya, A., Serwadda, D., et al. (2003) · Sexually Transmitted Infections · doi:10.1136/sti.79.2.98 · Cited by 64
The costs and effects of a nationwide insecticide-treated net programme: the case of Malawi
Stevens, W., Wiseman, V. L., Ortiz, J., & Chavasse, D. (2005) · Malaria Journal · doi:10.1186/1475-2875-4-22 · Cited by 59
Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?
Gutiérrez, J. P., Johns, B., Adam, T., Bertozzi, S., Edejer, T. T.-T., Greener, R., Hankins, C. A., & EVANS, D. B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16590-2 · Cited by 59
Panpanich, R., & Garner, P. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001443 · Cited by 57
Goodman, C. A., Coleman, P. G., & MILLS, A. J. (2001) · Health Economics · doi:10.1002/hec.621 · Cited by 35
SHARP, B. L., SUEUR, D. L., & Bekker, P. M. (1990) · PubMed · Cited by 29
Cited by
Wouters, O. J., Shadlen, K. C., Salcher-Konrad, M., Pollard, A. J., Larson, H. J., Teerawattananon, Y., & Jit, M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00306-8 · Cited by 1,288
Thresholds for the cost–effectiveness of interventions: alternative approaches
Marseille, E., Larson, B., Kazi, D. S., Kahn, J. G., & Rosen, S. (2015) · Bulletin of the World Health Organization · doi:10.2471/blt.14.138206 · Cited by 851
Diagnostic point-of-care tests in resource-limited settings
Drain, P. K., Hyle, E. P., Noubary, F., Freedberg, K. A., Wilson, D., Bishai, W. R., Rodriguez, W., & Bassett, I. V. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70250-0 · Cited by 744
Health Behavior in Developing Countries
Dupas, P. (2011) · Annual Review of Economics · doi:10.1146/annurev-economics-111809-125029 · Cited by 412
Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries
Adam, T., Lim, S. S., Mehta, S., Bhutta, Z. A., Fogstad, H., Mathai, M., Zupan, J., & Darmstadt, G. L. (2005) · BMJ · doi:10.1136/bmj.331.7525.1107 · Cited by 365
Metadata
- Authors
- Hogan, D. R., Baltussen, R., Hayashi, C., Lauer, J. A., & Salomon, J. A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2005-11-10
- Volume
- 331
- Issue
- 7530
- Pages
- 1431-1437
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W3132402962
- Cited by
- 253
- References
- 52
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.